0001181431-13-046225.txt : 20130823 0001181431-13-046225.hdr.sgml : 20130823 20130823090112 ACCESSION NUMBER: 0001181431-13-046225 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130822 FILED AS OF DATE: 20130823 DATE AS OF CHANGE: 20130823 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc. CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 7 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-444-8424 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 7 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Sarepta Therapuetics, Inc. DATE OF NAME CHANGE: 20120712 FORMER COMPANY: FORMER CONFORMED NAME: AVI BIOPHARMA INC DATE OF NAME CHANGE: 19980930 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CHASE ANTHONY R CENTRAL INDEX KEY: 0001223756 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 131056298 MAIL ADDRESS: STREET 1: 10307 PACIFIC CENTER COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 rrd388999.xml FORM 4 X0306 4 2013-08-22 0 0000873303 Sarepta Therapeutics, Inc. SRPT 0001223756 CHASE ANTHONY R 215 FIRST STREET, SUITE 7 CAMBRIDGE MA 02412 1 0 0 0 Common Stock 2013-08-22 4 P 0 3500 32.6781 A 31744 D This transaction was executed in multiple trades in prices ranging from $32.55 to $32.8099, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares acquired at each respective price within the range set forth in this footnote. /s/ Sandesh Mahatme For: Anthony R. Chase 2013-08-22